ROCHESTER, Minn., July 27, 2021 /PRNewswire/ -- Nanodropper,
Inc., a medical device company offering a first-of-its-kind eyedrop
bottle adaptor that reduces drop size, recently named its board of
directors following a successful seed funding round.
The board includes Seema Phull of
Golden Seeds and ForeOptics,
Chris Yoo, Ph.D., of Yoo and Co.
Accelerators, and Nanodropper CEO, Allisa
Song, who is also Chairwoman of the Board.
Seema is the founder of ForeOptics, a community of
entrepreneurs, practitioners, leaders, and subject-matter experts
who believe in giving back to society through volunteerism,
donations, and philanthropic work. She has 25 years of supply chain
management and transformation expertise, and has a deep
understanding of sales and operations planning and forecasting.
Chris has decades of experience in advancing cutting-edge
biomedical information technology in the healthcare and life
sciences industries. He also boasts an entrepreneurial streak, and
has created value in new companies that accelerate the adoption of
smarter, technology-based systems and devices. He co-founded and
served as director of Systems Oncology, LLC, an Arizona-based oncology biotechnology company,
and also co-founded and served as CEO of Systems Imagination, Inc.,
a pioneer in advanced cognitive computing technology and artificial
intelligence methodologies. He is currently an associate faculty in
biomedical informatics and diagnostics in the College of Health
Solutions at Arizona State
University.
Allisa is a serial entrepreneur and inventor with a background
in clinical medicine, neuroscience, and harm reduction. In addition
to her proven track record of successful fundraising, she has led
her teams to receive dozens of business and design awards and
recognitions, including most recently, 2021 Forbes 30 Under 30 list
in healthcare.
"Nanodropper's future is brighter than ever with a dedicated,
talented board that will empower our team's mission — providing
better access to vision-saving medications," says Allisa.
About Nanodropper, Inc.
Nanodropper offers
value-based solutions to close health equity gaps while promoting
patient education and advocacy. Named after the company's flagship
product, Nanodropper has developed a patient-centered adaptor for
eyedrop bottles to reduce the volume of currently oversized
eyedrops by more than 60 percent. This will help reduce cost,
decrease waste, and minimize potential side effects of
vision-saving treatments. Visit www.nanodropper.com to
learn more.
Contact:
Robbie Spencer
rspencer@nanodropper.com
View original
content:https://www.prnewswire.com/news-releases/nanodropper-announces-first-board-of-directors-301342450.html
SOURCE Nanodropper